DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Amicus Therapeutics, Inc. (FOLD)
« Back to company indexFOLD Chatter Timeline
Stock Ticker for FOLD
Most Active Tweeters for FOLD
No tweets foundRecent Tweets for FOLD
 |
@TheMarketsDaily Amicus Therapeutics, Inc. $FOLD Receives $19.67 Average Price Target from Analysts https://t.co/IoVwmQmlp0 August 21st 2018, 5:08pm |
|
@TheMarketsDaily Amicus Therapeutics $FOLD Cut to Strong Sell at BidaskClub https://t.co/dqdhdk1aN3 August 21st 2018, 6:08am |
 |
@WeekHerald Amicus Therapeutics $FOLD Downgraded by Chardan Capital https://t.co/2IulSV77Qp August 21st 2018, 5:08am |
 |
@ThisLincolnian Amicus Therapeutics $FOLD Downgraded by Chardan Capital https://t.co/h0rFOAIDHa August 21st 2018, 5:08am |
 |
@beyond_ninety Emory University Upped Amicus Therapeutics $FOLD Stake; Greywolf Capital Management LP Trimmed By $2.38 Million Its… https://t.co/N2Qfp2lZsJ August 20th 2018, 3:08pm |
 |
@ConsumerFeed Amicus Therapeutics $FOLD Downgraded by Chardan Capital https://t.co/4TofHO8NPe August 20th 2018, 5:08am |
 |
@usindexlive Amicus Therapeutics $FOLD Shareholder Artal Group Sa Has Lifted Holding by $16.50 Million as Stock Price Rose; Cond… https://t.co/a5PMSBnWSG August 20th 2018, 5:08am |
 |
@MareaInformativ Zacks: Brokerages Anticipate Amicus Therapeutics, Inc. $FOLD Will Announce Earnings of -$0.33 Per Share https://t.co/7juoPS8nsJ August 19th 2018, 11:08pm |
|
@TheMarketsDaily Amicus Therapeutics $FOLD Cut to Neutral at Chardan Capital https://t.co/YK3cyvZDam August 19th 2018, 11:08am |
|
@usindexlive Hudson Bay Capital Management LP Holds Holding in Amicus Therapeutics $FOLD; Neumeier Poma Investment Counsel Conti… https://t.co/twyJdERL2a August 19th 2018, 11:08am |
 |
@WatchlistN BidaskClub Lowers Amicus Therapeutics $FOLD to Strong Sell https://t.co/qfolsklXvg August 19th 2018, 9:08am |
 |
@bibeypost_stock Amicus Therapeutics, Inc. $FOLD's Stock Formed A Several Months Wedge Down - https://t.co/mkupcV7nU6 August 19th 2018, 9:08am |
 |
@mmahotstuff1 What Will Happen to Amicus Therapeutics, Inc. $FOLD Next? The Stock Formed a Several Months Wedge Down Chart Patter… https://t.co/gFPNayX2RS August 19th 2018, 9:08am |
 |
@reurope_stock Amicus Therapeutics, Inc. $FOLD's Bearish Wedge Down Pattern Points to Higher Stock Risks https://t.co/QySLr8aFU5 August 19th 2018, 9:08am |
 |
@west_moreland Does Amicus Therapeutics, Inc. $FOLD Have Any Gas After Forming This Bearish Wedge Down? https://t.co/aoYyiK9cWu August 19th 2018, 9:08am |
 |
@Fanob_stock What's Next for Amicus Therapeutics, Inc. $FOLD After Forming Bearish Wedge Down Chart Pattern? https://t.co/6IIqpiraru August 19th 2018, 9:08am |
 |
@pennyomegaCRWE Analysts' Viewpoints - $FOLD, $NTNX https://t.co/xI0i1AFOOZ https://t.co/AzGLFhqDyT August 19th 2018, 9:08am |
|
@ThisLincolnian Zacks: Brokerages Anticipate Amicus Therapeutics, Inc. $FOLD Will Announce Earnings of -$0.27 Per Share https://t.co/t5RZURvjZa August 18th 2018, 11:08pm |
 |
@OlympiaReport $23.31 Million in Sales Expected for Amicus Therapeutics, Inc. $FOLD This Quarter https://t.co/YSDgmEGaLR August 18th 2018, 11:08pm |
|
@WeekHerald Zacks: Analysts Expect Amicus Therapeutics, Inc. $FOLD Will Announce Earnings of -$0.27 Per Share https://t.co/2xVxPYBwOs August 18th 2018, 11:08pm |
|
@MareaInformativ $23.31 Million in Sales Expected for Amicus Therapeutics, Inc. $FOLD This Quarter https://t.co/xqKGkHyyRu August 18th 2018, 11:08pm |
 |
@EnterpriseLeade Amicus Therapeutics $FOLD Rating Increased to Strong-Buy at ValuEngine https://t.co/8gLAPQXIZD August 18th 2018, 6:08pm |
 |
@tgtxdough $FOLD catalysts: • 3Q18. AT-GAA: Type C meeting with FDA on Pompe disease program • 10 October 2018. Gene therapy:… https://t.co/NUqEKttgN0 August 18th 2018, 6:08pm |
|
@beyond_ninety Sectoral Asset Management Upped Amicus Therapeutics $FOLD Position; Vaxart $VXRT Sellers Decreased By 61.75% Their… https://t.co/MJ2E7STZ9U August 18th 2018, 12:08pm |
 |
@dakotafinancial Amicus Therapeutics $FOLD Downgraded to Strong Sell at BidaskClub https://t.co/cAK2y88LAt August 18th 2018, 7:08am |
 |
@AmericanBanking Amicus Therapeutics, Inc. $FOLD Given Consensus Rating of “Buy” by Analysts https://t.co/GLEktGkVIu #stocks August 18th 2018, 4:08am |
|
@ConsumerFeed Amicus Therapeutics, Inc. $FOLD Receives Average Recommendation of “Buy” from Brokerages https://t.co/6QHEmbVJ1c August 18th 2018, 4:08am |
 |
@IlliniJJ $FOLD most analysts have agendas, but this is an interesting take. could be sour grapes from not being involved in… https://t.co/lX5qpTj4ZR August 17th 2018, 1:08pm |
|
@AmericanBanking Amicus Therapeutics $FOLD Stock Rating Lowered by Chardan Capital https://t.co/5JQ6nqF7Sv #stocks August 17th 2018, 12:08pm |
|
@bibeypost_stock Shares of Amicus Therapeutics $FOLD Struck With Downgrade From Chardan Capital. Should Investors be Concerned? - https://t.co/LYYAsnfful August 17th 2018, 10:08am |
|
@mmahotstuff1 The Rating of Amicus Therapeutics $FOLD Shares By Chardan Capital Falls. $15 is now The Target Price per Share - https://t.co/Ez7mhJaZNJ August 17th 2018, 10:08am |
 |
@QuantchaIdeas Covered Call Alert: AMICUS THERAPEUTICS $FOLD returning up to 30.21% through 18-Jan-2019 https://t.co/jshg136rId https://t.co/76Yx76rVFT August 17th 2018, 10:08am |
 |
@whatsonthorold2 Should Investors Consider Selling Amicus Therapeutics $FOLD Shares Now That Chardan Capital Downgraded The Company?… https://t.co/53vBUbZHve August 17th 2018, 10:08am |
|
@reurope_stock Will Today’s Chardan Capital Downgrade Ultimately Hurt The Stock Price of Amicus Therapeutics $FOLD? https://t.co/Ff9Sgv4av5 August 17th 2018, 10:08am |
|
@west_moreland Is it Now Time For Investors to Consider Selling Amicus Therapeutics $FOLD Stock? Chardan Capital Downgrades The Co… https://t.co/0F0d1EzXUb August 17th 2018, 10:08am |
|
@Fanob_stock Has Chardan Capital Lost Faith in Amicus Therapeutics $FOLD After Recent Downgrade https://t.co/cOJruWnjJI August 17th 2018, 10:08am |
|
@bibeypost_stock Is Amicus Therapeutics $FOLD Really Worth Your Time and Dime After a Downgrade Today By Chardan Capital - https://t.co/mJouTnWJLz August 17th 2018, 10:08am |
|
@mmahotstuff1 Just How Negative is Chardan Capital on Amicus Therapeutics $FOLD Following Its Downgrade? The Target Price is $15 - https://t.co/55xYNYt3ZS August 17th 2018, 10:08am |
|
@reurope_stock Is Amicus Therapeutics $FOLD Really Worth Your Time and Dime After a Downgrade Today By Chardan Capital https://t.co/MTW4UEAghM August 17th 2018, 10:08am |
|
@whatsonthorold2 Will Today’s Chardan Capital Downgrade Ultimately Hurt The Stock Price of Amicus Therapeutics $FOLD? - https://t.co/tZVBEfCzou August 17th 2018, 10:08am |
|
@west_moreland The Rating of Amicus Therapeutics $FOLD Shares By Chardan Capital Falls. $15 is now The Target Price per Share https://t.co/oOjypPktaD August 17th 2018, 10:08am |
 |
@The_CasualSmart Does a Chardan Capital Downgrade Make Shares of Amicus Therapeutics $FOLD a Sell? https://t.co/7JwFH6HEf1 August 17th 2018, 10:08am |
 |
@BioWino downgrading because the stock hasn't gotten taken out yet. F'ing moronic thought process there. Chardan $fold. August 17th 2018, 10:08am |
|
@Fanob_stock Chardan Capital Decides to Give Amicus Therapeutics $FOLD a Lower Rating. The Target is Now $15 https://t.co/RufyQf2r7q August 17th 2018, 10:08am |
|
@BioWino $fold "US approval follows the recent successful Japan launch and strong Galafold adoption globally. Despite these… https://t.co/NtwujcEZyC August 17th 2018, 10:08am |
 |
@JSTOCKBROKERS RT @BioStocks: $FOLD downgraded from Buy to Neutral at Chardan. PT $15 August 17th 2018, 9:08am |
|
@bibeypost_stock Chardan Capital Markets Has Downgraded Shares of Amicus Therapeutics $FOLD Giving it a $15 Target Price per Share - https://t.co/GcRugTPkG4 August 17th 2018, 9:08am |
|
@bibeypost_stock Chardan Capital Markets: Downgrade Hits Shares of Amicus Therapeutics $FOLD - https://t.co/eTHo4ci21j August 17th 2018, 9:08am |
|
@reurope_stock The Rating of Amicus Therapeutics $FOLD Shares By Chardan Capital Markets Falls. $15 is now The Target https://t.co/TK4XW9Evx7 August 17th 2018, 9:08am |
|
@reurope_stock Should Investors Be Selling Amicus Therapeutics $FOLD Shares? Chardan Capital Markets Downgrades Stock https://t.co/QUWTCV7n8R August 17th 2018, 9:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.